Skip To Content
Jean-Philippe Bertrand

Jean-Philippe Bertrand

Associate, Corporate

Contact Information

tel: 514.904.5836



Areas of Expertise
Bar Admission

Quebec, 2016


University of Montreal, LL.B.

China University of Political Science and Law

English, French

Jean-Philippe is an associate in our Montreal office and is a member of the corporate group. He practices corporate and securities law, with an emphasis on corporate finance, mergers and acquisitions and venture capital.

  • Neptune Wellness Solutions Inc.

    Neptune Wellness Solutions in its proposed acquisition of SugarLeaf for up to US$150 million

  • Abacus Health Products Inc.

    Abacus Health Products in its $34 million financing

  • Vervent Audio Group

    Vervent Audio Group in its acquisition of Audio Plus Services & Plurison

  • Abacus Health Products

    Abacus Health Products in its going public transaction by way of a reverse takeover, US$15 million concurrent financing and listing on the Canadian Securities Exchange

  • CAE Inc.

    CAE Inc. in its acquisition of Bombardier’s Business Aircraft Training (BAT) business for US$645 million

  • Dialogue Technologies Inc.

    Dialogue Technologies Inc. in its acquisition of DXA

  • Alithya Group Inc.

    Alithya Group Inc., in its going public transaction by way of a business combination with Edgewater Technology, Inc. and completion of a $52.8 million concurrent private placement

  • Behaviour Interactive Inc.

    Behaviour Interactive Inc. in its strategic partnership agreement with GAEA Interactive Entertainment Co. Ltd.

  • Angiochem Inc.

    Angiochem Inc. in its Series C financing round of $7.5 million

  • The Stars Group Inc.

    The Stars Group Inc. in its US$950 million public offering of common shares

    • IQVIA in its acquisition, with private equity fund manager Imperial Capital Group, of STI Technologies Limited, a supplier of outsourced pharmaceutical technologies and services.
    • The Caisse de dépôt et placement du Québec, in several venture capital investments.
    • Prometic Life Sciences Inc., a company listed on the Toronto Stock Exchange, in the closing of an equity bought deal of 31,250,000 common shares, through a syndicate of underwriters, for total gross proceeds of $53,125,000, and in the concurrent private placement with Structured Alpha LP for the purchase of 5,045,369 common shares.
    • Fonds de Solidarité FTQ for an investment of risk capital in Kaloom Inc. (Montréal- and Silicon Valley-based software).
    • Ressources Québec Inc. in the context of a $10,000,000 private placement of units of Falco Resources Ltd., a TSX Venture Exchange listed issuer.
    • Taro Pharmaceuticals Inc. in its acquisition of Thallion Pharmacutiques Inc., a wholly owned subsidiary of BELLUS Health Inc., including all the rights to the drug candidate ShigamabTM.
    • CiToxLAB Group Inc. in its acquisition of AccelLAB Inc.
    • GDG Environnement upon the sale of all of its issued and outstanding shares to Choisy Laboratories Ltd.
    • Ressources Québec Inc. in the context of a $10,000,000 private placement of units of Nemaska Lithium Inc., a TSX Venture Exchange listed issuer.
  • Find More

  • Barreau du Québec

  • Young Bar Association of Montréal

  • Canadian Bar Association